Literature DB >> 1774274

Diagnosis of acute pulmonary toxoplasmosis by visualization of invasive and intracellular tachyzoites in Giemsa-stained smears of bronchoalveolar lavage fluid.

E J Bottone1.   

Abstract

Two patients with AIDS presented with pulmonary toxoplasmosis. Diagnosis was achieved by the visualization, in Giemsa-stained smears of bronchoalveolar lavage fluid, of tachyzoites of Toxoplasma gondii that were extracellular and in the process of invading or within pneumocytes. The intracellular localization of tachyzoites facilitated diagnosis by obviating potential confusion of extracellular tachyzoites with cellular debris or platelets.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774274      PMCID: PMC270389          DOI: 10.1128/jcm.29.11.2626-2627.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Laboratory diagnosis of pulmonary toxoplasmosis in patients with acquired immunodeficiency syndrome.

Authors:  F Derouin; C Sarfati; B Beauvais; M C Iliou; L Dehen; M Lariviere
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

2.  Pulmonary toxoplasmosis.

Authors:  J R Catterall; J M Hofflin; J S Remington
Journal:  Am Rev Respir Dis       Date:  1986-04

3.  Unusual pulmonary infection in a puzzling presentation of AIDS.

Authors:  J M Tourani; D Israël-Biet; A Venet; J M Andrieu
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

4.  [Detection of a pulmonary localization of Toxoplasma gondii in an immunosuppressed patient].

Authors:  A Bendelac; J P Laporte; M Marteau; G Mougeot; A Najman; J L Poirot; P Roux
Journal:  Presse Med       Date:  1984-05-05       Impact factor: 1.228

5.  Immunohistologic demonstration of Toxoplasma gondii.

Authors:  S Z Tabei
Journal:  N Engl J Med       Date:  1982-11-25       Impact factor: 91.245

6.  Role of bronchoalveolar lavage in diagnosis of disseminated toxoplasmosis.

Authors:  F Jacobs; M Depierreux; M Goldman; M Hall; C Liesnard; F Janssen; C Toussaint; J P Thys
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

7.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

8.  Pulmonary toxoplasmosis in AIDS.

Authors:  M H Mendelson; L J Finkel; B R Meyers; J P Lieberman; S Z Hirschman
Journal:  Scand J Infect Dis       Date:  1987

9.  Use of the transbronchial biopsy for diagnosis of opportunistic pulmonary infections in acquired immunodeficiency syndrome (AIDS).

Authors:  W Blumenfeld; E Wagar; W K Hadley
Journal:  Am J Clin Pathol       Date:  1984-01       Impact factor: 2.493

10.  Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections.

Authors:  F K Conley; K A Jenkins; J S Remington
Journal:  Hum Pathol       Date:  1981-08       Impact factor: 3.466

View more
  4 in total

Review 1.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

2.  Detection of Toxoplasma gondii in AIDS patients by the polymerase chain reaction.

Authors:  N Cristina; H Pelloux; C Goulhot; J P Brion; P Leclercq; P Ambroise-Thomas
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

3.  Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis.

Authors:  A Roth; B Roth; K N Arasteh; K Janitschke
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

4.  Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients.

Authors:  A Roth; B Roth; G Höffken; S Steuber; K I Khalifa; K Janitschke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.